These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28839469)

  • 1. RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
    Liu T; Li W; Lu W; Chen M; Luo M; Zhang C; Li Y; Qin G; Shi D; Xiao B; Qiu H; Yu W; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Theranostics; 2017; 7(12):3138-3154. PubMed ID: 28839469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
    Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
    Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBFOX3 Regulates the Chemosensitivity of Cancer Cells to 5-Fluorouracil via the PI3K/AKT, EMT and Cytochrome-C/Caspase Pathways.
    Liu T; Wu X; Li Y; Lu W; Zheng F; Zhang C; Long Q; Qiu H; Li Y; Ge Q; Chen M; Yu X; Chen W; Zhang H; Huang W; Luo M; Deng W; Li L
    Cell Physiol Biochem; 2018; 46(4):1365-1380. PubMed ID: 29689552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
    Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH
    J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling.
    Luo C; Zhu X; Luo Q; Bu F; Huang C; Zhu J; Zhao J; Zhang W; Lin K; Hu C; Zong Z; Luo H; Huang J; Zhu Z
    Front Oncol; 2020; 10():1044. PubMed ID: 32903312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.
    Zhang N; Zhang R; Zou K; Yu W; Guo W; Gao Y; Li J; Li M; Tai Y; Huang W; Song C; Deng W; Cui X
    Cell Death Dis; 2017 Jul; 8(7):e2961. PubMed ID: 28749462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells.
    Deng WG; Jayachandran G; Wu G; Xu K; Roth JA; Ji L
    J Biol Chem; 2007 Sep; 282(36):26460-70. PubMed ID: 17630431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.
    Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C
    Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells.
    Chen W; Lu J; Qin Y; Wang J; Tian Y; Shi D; Wang S; Xiao Y; Dai M; Liu L; Wei G; Wu T; Jin B; Xiao X; Kang TB; Huang W; Deng W
    Oncotarget; 2014 Dec; 5(23):11909-23. PubMed ID: 25481043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers.
    Guo W; Lu J; Dai M; Wu T; Yu Z; Wang J; Chen W; Shi D; Yu W; Xiao Y; Yi C; Tang Z; Xu T; Xiao X; Yuan Y; Liu Q; Du G; Deng W
    Oncotarget; 2014 Oct; 5(19):9349-61. PubMed ID: 25294805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin inhibits MLL-rearranged leukemia via RBFOX3/hTERT and NF-κB/COX-2 signaling pathways.
    Tang YL; Sun X; Huang LB; Liu XJ; Qin G; Wang LN; Zhang XL; Ke ZY; Luo JS; Liang C; Peng CJ; Tang WY; Li Y; Huang W; Luo XQ; Deng W
    Cancer Lett; 2019 Feb; 443():167-178. PubMed ID: 30550850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway.
    Zhang C; Song C; Liu T; Tang R; Chen M; Gao F; Xiao B; Qin G; Shi F; Li W; Li Y; Fu X; Shi D; Xiao X; Kang L; Huang W; Wu X; Tang B; Deng W
    Cell Death Dis; 2017 Jul; 8(7):e2940. PubMed ID: 28726783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin as a critical regulator of hepatocellular carcinoma development through modulation of human telomerase reverse transcriptase.
    Stefanou N; Papanikolaou V; Furukawa Y; Nakamura Y; Tsezou A
    BMC Cancer; 2010 Aug; 10():442. PubMed ID: 20723213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDC5L Promotes hTERT Expression and Colorectal Tumor Growth.
    Li J; Zhang N; Zhang R; Sun L; Yu W; Guo W; Gao Y; Li M; Liu W; Liang P; Deng W; Cui X
    Cell Physiol Biochem; 2017; 41(6):2475-2488. PubMed ID: 28472785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner.
    Gai X; Zhao P; Pan Y; Shan H; Yue X; Du J; Zhang Z; Liu P; Ma H; Guo M; Yang X; Sun W; Gao L; Ma C; Liang X
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1174-85. PubMed ID: 23542016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
    Chen R; Zhu J; Dong Y; He C; Hu X
    Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NRF2-dependent transcriptional axis, XRCC5/hTERT drives tumor progression and 5-Fu insensitivity in hepatocellular carcinoma.
    Liu T; Long Q; Li L; Gan H; Hu X; Long H; Yang L; Pang P; Wang S; Deng W
    Mol Ther Oncolytics; 2022 Mar; 24():249-261. PubMed ID: 35071747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDB2 promotes melanoma cell growth by transcriptionally regulating the expression of KMT2A and predicts a poor prognosis.
    Zhang C; Li W; Liu L; Li M; Sun H; Zhang C; Zhong L; Huang J; Li T
    FASEB J; 2024 Jun; 38(12):e23735. PubMed ID: 38860936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.
    Mizukoshi E; Nakamoto Y; Marukawa Y; Arai K; Yamashita T; Tsuji H; Kuzushima K; Takiguchi M; Kaneko S
    Hepatology; 2006 Jun; 43(6):1284-94. PubMed ID: 16729333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.